(915732, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915733, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915734, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915735, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915736, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915737, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915738, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915739, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915740, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915741, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915742, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915743, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915744, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915745, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915746, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915747, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915748, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915749, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915750, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915751, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915752, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915753, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915754, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915755, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915756, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915757, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915758, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915759, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915760, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915761, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915762, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915763, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915764, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915765, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915766, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915767, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915768, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915769, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915770, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915771, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915772, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915773, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915774, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915775, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915776, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915777, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915778, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915779, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915780, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915781, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915782, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915783, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915784, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915785, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915786, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915787, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915788, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915789, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915790, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915791, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915792, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915793, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915794, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915795, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915796, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915797, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915798, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915799, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915800, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915801, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915802, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915803, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915804, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915805, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915806, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915807, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915808, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915809, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915810, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915811, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915812, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915813, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915814, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915815, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915816, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915817, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915818, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915819, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915820, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915821, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915822, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915823, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915824, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915825, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915826, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915827, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915828, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915829, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915830, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915831, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915832, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915833, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915834, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915835, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915836, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915837, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915838, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915839, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915840, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915841, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915842, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915843, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915844, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915845, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915846, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915847, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915848, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915849, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915850, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915851, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915852, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915853, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915854, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915855, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915856, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915857, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915858, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915859, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915860, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915861, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915862, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915863, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915864, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915865, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915866, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915867, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915868, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915869, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915870, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915871, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915872, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915873, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915874, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915875, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915876, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915877, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915878, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915879, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915880, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915881, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915882, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915883, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915884, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915885, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915886, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915887, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915888, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915889, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915890, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915891, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915892, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915893, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915894, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915895, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915896, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915897, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915898, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915899, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915900, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915901, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915902, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915903, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915904, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915905, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915906, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915907, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915908, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915909, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915910, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915911, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915912, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915913, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915914, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915915, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915916, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915917, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915918, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915919, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915920, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915921, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915922, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915923, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915924, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915925, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915926, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915927, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915928, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915929, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915930, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915931, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915932, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915933, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915934, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915935, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915936, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915937, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915938, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915939, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915940, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915941, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915942, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915943, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915944, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915945, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915946, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915947, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915948, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915949, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915950, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915951, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915952, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915953, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915954, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915955, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915956, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915957, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915958, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915959, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915960, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915961, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915962, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915963, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915964, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915965, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915966, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915967, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915968, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915969, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915970, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915971, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915972, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915973, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915974, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915975, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915976, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915977, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915978, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915979, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915980, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915981, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915982, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915983, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915984, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915985, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915986, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915987, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915988, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915989, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915990, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915991, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915992, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915993, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915994, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915995, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915996, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(915997, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915998, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(915999, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916000, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916001, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916002, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916003, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916004, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916005, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916006, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916007, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916008, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916009, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916010, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916011, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916012, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916013, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916014, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916015, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916016, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916017, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916018, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916019, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916020, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916021, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916022, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916023, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916024, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916025, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916026, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916027, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916028, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916029, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916030, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916031, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916032, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916033, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916034, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916035, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916036, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916037, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916038, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916039, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916040, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916041, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916042, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916043, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916044, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916045, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916046, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916047, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916048, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916049, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916050, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916051, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916052, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916053, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916054, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916055, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916056, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916057, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916058, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916059, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916060, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916061, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916062, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916063, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916064, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916065, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916066, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916067, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916068, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916069, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916070, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916071, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916072, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916073, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916074, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916075, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916076, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916077, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916078, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916079, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916080, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916081, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916082, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916083, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916084, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916085, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916086, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916087, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916088, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916089, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916090, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916091, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916092, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916093, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916094, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916095, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916096, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916097, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916098, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916099, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916100, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916101, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916102, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916103, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916104, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916105, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916106, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916107, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916108, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916109, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916110, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916111, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916112, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916113, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916114, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916115, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916116, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916117, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916118, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916119, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916120, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916121, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916122, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916123, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916124, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916125, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916126, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916127, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916128, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916129, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916130, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916131, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916132, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916133, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916134, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916135, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916136, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916137, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916138, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916139, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916140, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916141, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916142, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916143, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916144, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916145, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916146, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916147, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916148, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916149, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916150, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916151, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916152, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916153, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916154, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916155, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916156, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916157, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916158, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916159, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916160, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916161, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916162, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916163, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916164, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916165, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916166, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916167, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916168, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916169, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916170, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916171, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916172, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916173, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916174, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916175, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916176, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916177, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916178, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916179, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916180, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916181, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916182, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916183, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916184, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916185, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916186, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916187, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916188, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916189, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916190, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916191, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916192, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916193, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916194, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916195, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916196, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916197, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916198, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916199, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916200, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916201, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916202, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916203, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916204, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916205, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916206, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916207, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916208, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916209, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916210, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916211, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916212, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916213, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916214, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916215, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916216, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916217, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916218, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916219, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916220, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916221, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916222, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916223, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916224, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916225, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916226, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916227, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916228, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916229, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916230, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916231, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916232, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916233, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916234, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916235, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916236, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916237, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916238, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916239, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916240, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916241, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916242, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916243, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916244, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916245, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916246, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916247, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916248, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916249, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916250, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916251, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916252, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916253, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916254, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916255, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916256, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916257, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916258, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916259, 'HP:0034108', 'Anti-Y-box protein-1 antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(916260, 'HP:0025676', 'Fetal pleural effusion', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916261, 'HP:0025676', 'Fetal pleural effusion', 'MP:0014134', 'abnormal embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916262, 'HP:0025676', 'Fetal pleural effusion', 'MP:0002111', 'abnormal tail morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916263, 'HP:0025676', 'Fetal pleural effusion', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916264, 'HP:0025676', 'Fetal pleural effusion', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916265, 'HP:0025676', 'Fetal pleural effusion', 'MP:0003385', 'abnormal body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916266, 'HP:0025676', 'Fetal pleural effusion', 'MP:0005500', 'abnormal gustatory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916267, 'HP:0025676', 'Fetal pleural effusion', 'MP:0005499', 'abnormal olfactory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916268, 'HP:0025676', 'Fetal pleural effusion', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916269, 'HP:0025676', 'Fetal pleural effusion', 'MP:0002163', 'abnormal gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(916270, 'HP:0410019', 'Epigastric pain', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916271, 'HP:0410019', 'Epigastric pain', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916272, 'HP:0410019', 'Epigastric pain', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916273, 'HP:0410019', 'Epigastric pain', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916274, 'HP:0410019', 'Epigastric pain', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(916275, 'HP:0410019', 'Epigastric pain', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916276, 'HP:0410019', 'Epigastric pain', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916277, 'HP:0410019', 'Epigastric pain', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916278, 'HP:0410019', 'Epigastric pain', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916279, 'HP:0410019', 'Epigastric pain', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916280, 'HP:0410019', 'Epigastric pain', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916281, 'HP:0410019', 'Epigastric pain', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916282, 'HP:0410019', 'Epigastric pain', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916283, 'HP:0410019', 'Epigastric pain', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916284, 'HP:0410019', 'Epigastric pain', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916285, 'HP:0410019', 'Epigastric pain', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916286, 'HP:0410019', 'Epigastric pain', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916287, 'HP:0410019', 'Epigastric pain', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916288, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0003014', 'abnormal kidney medulla morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916289, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916290, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0002135', 'abnormal kidney morphology', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916291, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011381', 'abnormal kidney lobe morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916292, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0000521', 'abnormal kidney cortex morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916293, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0012024', 'abnormal nephron morphogenesis', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916294, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0009860', 'nephrosclerosis', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916295, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011379', 'abnormal kidney outer medulla outer stripe morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916296, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0000527', 'abnormal kidney development', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916297, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0003881', 'abnormal nephron morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916298, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011364', 'abnormal metanephros morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916299, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011383', 'abnormal kidney capsule morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916300, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916301, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0003675', 'kidney cyst', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916302, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0004195', 'abnormal kidney calyx morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916303, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0003197', 'nephrocalcinosis', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916304, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916305, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916306, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0002706', 'abnormal kidney size', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916307, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0004969', 'pale kidney', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916308, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916309, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0002703', 'abnormal renal tubule morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916310, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011402', 'renal cast', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916311, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916312, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916313, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011334', 'abnormal nephrogenic zone morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916314, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0003613', 'abnormal kidney medulla development', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916315, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011378', 'abnormal kidney outer medulla inner stripe morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916316, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011534', 'granular kidney', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916317, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0003985', 'renal fibrosis', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916318, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916319, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916320, 'HP:0033900', 'Renal arteriole intima/media amyloidosis', 'MP:0011382', 'abnormal kidney lobule morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(916321, 'HP:0030284', 'Triangular tongue', 'MP:0009906', 'increased tongue size', 0.43283582089552236, 15.607147267911275, 2.599102229529205, 'UPHENO:0001398', 'increased size of the tongue'),
(916322, 'HP:0100014', 'Epiretinal membrane', 'MP:0020443', 'tractional retina detachment', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(916323, 'HP:0100014', 'Epiretinal membrane', 'MP:0006186', 'retina fibrosis', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(916324, 'HP:0100014', 'Epiretinal membrane', 'MP:0001329', 'retina hyperplasia', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(916325, 'HP:0100014', 'Epiretinal membrane', 'MP:0006188', 'calcified retina', 0.42424242424242425, 9.356059413574362, 1.9922944880139937, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(916326, 'HP:0100014', 'Epiretinal membrane', 'MP:0003099', 'retina detachment', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(916327, 'HP:0100014', 'Epiretinal membrane', 'MP:0020442', 'serous retina detachment', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(916328, 'HP:0100014', 'Epiretinal membrane', 'MP:0001326', 'retina degeneration', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(916329, 'HP:0100014', 'Epiretinal membrane', 'MP:0020441', 'rhegmatogenous retina detachment', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(916330, 'HP:0100014', 'Epiretinal membrane', 'MP:0020038', 'retina macular degeneration', 0.417910447761194, 12.083585311854263, 2.247188587599537, 'UPHENO:0076777', 'abnormal macula lutea morphology'),
(916331, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0031484', 'increased urine hypoxanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916332, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0031481', 'decreased urine xanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916333, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0002987', 'abnormal urine osmolality', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916334, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0004052', 'decreased renal sympathetic nerve activity', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916335, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011297', 'absent tubuloglomerular feedback response', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916336, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0031480', 'abnormal urine xanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916337, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916338, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916339, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011417', 'abnormal renal transport', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916340, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0003589', 'abnormal ureter physiology', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916341, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0009349', 'increased urine pH', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916342, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0031479', 'increased urine xanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916343, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0014037', 'stranguria', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916344, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011758', 'renal ischemia', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916345, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011431', 'increased urine flow rate', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916346, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011418', 'leukocyturia', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916347, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916348, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011420', 'pyuria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916349, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0010107', 'abnormal renal reabsorption', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916350, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011467', 'decreased urine urea nitrogen level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916351, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0009645', 'crystalluria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916352, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0002136', 'abnormal kidney physiology', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916353, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0008055', 'increased urine osmolality', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916354, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0004051', 'increased renal sympathetic nerve activity', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916355, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0031404', 'increased tubuloglomerular feedback response', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916356, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011296', 'decreased tubuloglomerular feedback response', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916357, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0001761', 'abnormal urination pattern', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916358, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011444', 'abnormal renal water homeostasis', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916359, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011295', 'abnormal tubuloglomerular feedback response', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916360, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0013285', 'abnormal renal filtration', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916361, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0013305', 'isosthenuria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916362, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916363, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011421', 'cylindruria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916364, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0002893', 'ketoaciduria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916365, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916366, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0003280', 'urinary incontinence', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916367, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011466', 'increased urine urea nitrogen level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916368, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.5, 8.666588959537362, 2.081656667120849, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916369, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0009350', 'decreased urine pH', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916370, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0003621', 'dysuria', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916371, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0010386', 'abnormal urinary bladder physiology', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916372, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0002988', 'decreased urine osmolality', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916373, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0010028', 'aciduria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916374, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0030619', 'homogentisic aciduria', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916375, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0001948', 'vesicoureteral reflux', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916376, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916377, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011432', 'decreased urine flow rate', 0.4666666666666667, 8.666588959537362, 2.011071401297685, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916378, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0004050', 'abnormal renal sympathetic nerve activity', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916379, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0006273', 'abnormal urine organic cation level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916380, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916381, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0001760', 'abnormal urine enzyme level', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916382, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011900', 'podocyturia', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916383, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0009348', 'abnormal urine pH', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916384, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916385, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011442', 'abnormal renal sodium ion transport', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916386, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0000327', 'hemosiderinuria', 0.4375, 8.666588959537362, 1.947211511314987, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916387, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0031483', 'decreased urine hypoxanthine level', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916388, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0001756', 'abnormal urination', 0.4827586206896552, 8.666588959537362, 2.045451180593282, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916389, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0009643', 'abnormal urine homeostasis', 0.45161290322580644, 8.666588959537362, 1.9783688738658898, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916390, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0013284', 'abnormal renal glomerular filtration', 0.4117647058823529, 8.666588959537362, 1.8890726438988916, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916391, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916392, 'HP:0034613', 'Elevated urine erythritol level', 'MP:0011923', 'abnormal bladder urine volume', 0.42424242424242425, 8.666588959537362, 1.9174813454390527, 'UPHENO:0002442', 'abnormality of renal system physiology'),
(916393, 'HP:0006880', 'Cerebellar hemangioblastoma', 'MP:0020538', 'abnormal cerebellum fastigial nucleus size', 0.40384615384615385, 9.732678149995134, 1.9825500340465647, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(916394, 'HP:0006880', 'Cerebellar hemangioblastoma', 'MP:0012262', 'abnormal hindbrain size', 0.4166666666666667, 10.879226813348076, 2.1290869339292757, 'UPHENO:0020013', 'abnormal hindbrain morphology'),
(916395, 'HP:0006880', 'Cerebellar hemangioblastoma', 'MP:0000852', 'small cerebellum', 0.42, 9.732678149995134, 2.021812262055495, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(916396, 'HP:0006880', 'Cerebellar hemangioblastoma', 'MP:0008914', 'enlarged cerebellum', 0.42, 9.732678149995134, 2.021812262055495, 'UPHENO:0076720', 'abnormal cerebellum morphology'),
(916397, 'HP:0005213', 'Pancreatic calcification', 'MP:0014108', 'calcified pancreas', 0.47368421052631576, 16.607147267911277, 2.804735895355357, 'UPHENO:0067776', 'pancreas calcification'),
(916398, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030618', 'tryptophanuria', 0.5256410256410257, 11.226325483970346, 2.4292009471375886, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916399, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0011654', 'histidinuria', 0.5256410256410257, 11.226325483970346, 2.4292009471375886, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916400, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0003311', 'aminoaciduria', 0.547945205479452, 11.226325483970346, 2.4802038674458475, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916401, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030682', 'hydroxyprolinuria', 0.5121951219512195, 11.226325483970346, 2.397930180452774, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916402, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0020402', 'ornithinuria', 0.5185185185185185, 11.226325483970346, 2.4126868131514696, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916403, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0020404', 'prolinuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916404, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030615', 'ethylmalonic aciduria', 0.4024390243902439, 10.47786425096631, 2.0534608510639534, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(916405, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0011470', 'increased urine creatinine level', 0.4342105263157895, 11.094077685671904, 2.1948041623078476, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(916406, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0020401', 'argininuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916407, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0020400', 'cystinuria', 0.5454545454545454, 11.226325483970346, 2.474560620389774, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916408, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030614', 'methylmalonic aciduria', 0.4074074074074074, 10.47786425096631, 2.066097652496837, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(916409, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0002931', 'glutaricadicuria', 0.4024390243902439, 10.47786425096631, 2.0534608510639534, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(916410, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0020405', 'taurinuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916411, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0011516', 'aspartylglucosaminuria', 0.5405405405405406, 11.226325483970346, 2.4633887320902836, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916412, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.5185185185185185, 11.226325483970346, 2.4126868131514696, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916413, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030616', 'hyperglycinuria', 0.4880952380952381, 11.226325483970346, 2.3408366047277083, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916414, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030632', 'increased urine creatine level', 0.41975308641975306, 11.094077685671904, 2.1579558265963863, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(916415, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0020403', 'lysinuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916416, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0011765', 'oroticaciduria', 0.4794520547945205, 10.47786425096631, 2.241346368811355, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(916417, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030617', 'hyperglutaminuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916418, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030620', 'valinuria', 0.4939759036144578, 11.226325483970346, 2.3548958098426067, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916419, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030689', 'cystathioninuria', 0.5185185185185185, 11.226325483970346, 2.4126868131514696, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916420, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0030613', 'dicarboxylic aciduria', 0.4383561643835616, 10.47786425096631, 2.143137042744871, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(916421, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0013730', 'glutathionuria', 0.5060240963855421, 11.226325483970346, 2.3834410436920983, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916422, 'HP:0410132', 'Increased level of L-pyroglutamic acid in urine', 'MP:0020406', 'hyperthreoninuria', 0.5061728395061729, 11.226325483970346, 2.383791317930699, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(916423, 'HP:0100242', 'Sarcoma', 'MP:0003385', 'abnormal body wall morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916424, 'HP:0100242', 'Sarcoma', 'MP:0021145', 'abnormal amino acid derivative level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916425, 'HP:0100242', 'Sarcoma', 'MP:0002163', 'abnormal gland morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916426, 'HP:0100242', 'Sarcoma', 'MP:0011475', 'abnormal glycosaminoglycan level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916427, 'HP:0100242', 'Sarcoma', 'MP:0000001', 'mammalian phenotype', 0.42857142857142855, 1.5524157786304194, 0.8156721449114622, 'UPHENO:0001003', 'phenotype by ontology source'),
(916428, 'HP:0100242', 'Sarcoma', 'MP:0002111', 'abnormal tail morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916429, 'HP:0100242', 'Sarcoma', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916430, 'HP:0100242', 'Sarcoma', 'MP:0011479', 'abnormal catecholamine level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916431, 'HP:0100242', 'Sarcoma', 'MP:0005332', 'abnormal amino acid level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916432, 'HP:0100242', 'Sarcoma', 'MP:0021122', 'abnormal trimethylamine N-oxide level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916433, 'HP:0100242', 'Sarcoma', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916434, 'HP:0100242', 'Sarcoma', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916435, 'HP:0100242', 'Sarcoma', 'MP:0008469', 'abnormal protein level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916436, 'HP:0100242', 'Sarcoma', 'MP:0014134', 'abnormal embryo morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916437, 'HP:0100242', 'Sarcoma', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916438, 'HP:0100242', 'Sarcoma', 'MP:0005499', 'abnormal olfactory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916439, 'HP:0100242', 'Sarcoma', 'MP:0005500', 'abnormal gustatory system morphology', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916440, 'HP:0100242', 'Sarcoma', 'MP:0011989', 'abnormal porphyrin level', 0.42105263157894735, 1.6758249395539064, 0.8400062504915083, 'UPHENO:0001005', 'abnormal phenotype by ontology source'),
(916441, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916442, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011397', 'endoneurial edema', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916443, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916444, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001912', 'increased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916445, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916446, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916447, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916448, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916449, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916450, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014179', 'abnormal blood-retina barrier function', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916451, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012006', 'abnormal hippocampus physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916452, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916453, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916454, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003633', 'abnormal nervous system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916455, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916456, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916457, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916458, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004859', 'abnormal synaptic plasticity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916459, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916460, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916461, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916462, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008840', 'abnormal spike wave discharge', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916463, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916464, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916465, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916466, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916467, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004752', 'decreased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916468, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001915', 'intracranial hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916469, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916470, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003996', 'clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916471, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916472, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916473, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916474, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916475, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005403', 'abnormal nerve conduction', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916476, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916477, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002723', 'abnormal immune serum protein physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916478, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916479, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916480, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916481, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916482, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916483, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916484, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005005', 'abnormal self tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916485, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916486, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020155', 'enhanced humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916487, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916488, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916489, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001800', 'abnormal humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916490, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916491, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001846', 'increased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916492, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916493, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003990', 'decreased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916494, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002826', 'tonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916495, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916496, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011399', 'increased endoneurial fluid pressure', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916497, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916498, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002923', 'increased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916499, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916500, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916501, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003219', 'increased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916502, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916503, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004495', 'decreased synaptic glutamate release', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916504, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020001', 'decreased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916505, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916506, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916507, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916508, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012011', 'febrile seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916509, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008814', 'decreased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916510, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916511, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002914', 'abnormal endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916512, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916513, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916514, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916515, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916516, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916517, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916518, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916519, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916520, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916521, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916522, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002064', 'seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916523, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003635', 'abnormal synaptic transmission', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916524, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916525, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916526, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916527, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916528, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916529, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916530, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916531, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916532, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003469', 'decreased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916533, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003473', 'decreased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916534, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002421', 'abnormal cell-mediated immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916535, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009967', 'abnormal neuron proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916536, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916537, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916538, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013806', 'encephalopathy', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916539, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916540, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003008', 'enhanced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916541, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916542, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916543, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916544, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002499', 'chronic inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916545, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916546, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916547, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916548, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005671', 'abnormal response to transplant', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916549, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003762', 'abnormal immune organ physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916550, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003472', 'increased summary potential threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916551, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916552, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003465', 'increased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916553, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014178', 'increased brain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916554, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916555, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916556, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916557, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003463', 'abnormal single cell response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916558, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009358', 'environmentally induced seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916559, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004513', 'avnosmia', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916560, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916561, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916562, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916563, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916564, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916565, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916566, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916567, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003471', 'abnormal summary potential threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916568, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916569, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916570, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916571, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916572, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916573, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916574, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003474', 'abnormal summary potential intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916575, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003202', 'abnormal neuron apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916576, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916577, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916578, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916579, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916580, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916581, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916582, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006053', 'hypothalamus hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916583, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916584, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002193', 'minimal clonic seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916585, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003476', 'decreased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916586, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916587, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000951', 'sporadic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916588, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916589, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916590, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916591, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004768', 'abnormal axonal transport', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916592, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916593, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003470', 'abnormal summary potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916594, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916595, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916596, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916597, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003485', 'abnormal channel response threshold', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916598, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0030990', 'nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916599, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006058', 'decreased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916600, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916601, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916602, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916603, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916604, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916605, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916606, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916607, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020002', 'increased response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916608, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916609, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010050', 'hypermyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916610, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001835', 'abnormal antigen presentation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916611, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916612, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021001', 'impaired neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916613, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916614, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916615, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916616, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004835', 'abnormal miniature endplate potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916617, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916618, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031109', 'subarachnoid hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916619, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916620, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916621, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003216', 'absence seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916622, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003486', 'abnormal channel response intensity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916623, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916624, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916625, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916626, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916627, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916628, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916629, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011994', 'increased nerve conduction velocity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916630, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916631, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916632, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916633, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003412', 'abnormal afterhyperpolarization', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916634, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916635, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916636, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916637, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916638, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916639, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916640, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916641, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916642, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916643, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009141', 'increased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916644, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916645, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916646, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001752', 'abnormal hypothalamus secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916647, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916648, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916649, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021010', 'impaired synaptic physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916650, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916651, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916652, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916653, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916654, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916655, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002195', 'psychomotor seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916656, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916657, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916658, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020371', 'abnormal glymphatic system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916659, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006054', 'spinal hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916660, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916661, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916662, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916663, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003217', 'increased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916664, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916665, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916666, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916667, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020000', 'abnormal response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916668, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916669, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916670, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005000', 'abnormal immune tolerance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916671, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003483', 'decreased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916672, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916673, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916674, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916675, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916676, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916677, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916678, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916679, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916680, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003997', 'tonic-clonic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916681, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014252', 'abnormal paired-pulse ratio', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916682, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916683, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002419', 'abnormal innate immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916684, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003484', 'abnormal channel response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916685, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916686, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002916', 'increased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916687, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916688, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009142', 'decreased prepulse inhibition', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916689, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916690, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916691, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013182', 'increased spinal cord apoptosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916692, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916693, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005004', 'abnormal lymphocyte anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916694, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000947', 'convulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916695, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916696, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916697, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002917', 'decreased synaptic depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916698, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003467', 'abnormal single cell response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916699, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916700, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916701, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916702, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916703, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916704, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003475', 'increased summary potential intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916705, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916706, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916707, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916708, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916709, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916710, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916711, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916712, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003490', 'decreased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916713, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003487', 'increased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916714, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916715, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003482', 'increased nerve fiber response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916716, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916717, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916718, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001500', 'decreased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916719, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916720, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916721, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916722, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916723, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916724, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916725, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003088', 'abnormal prepulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916726, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916727, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005001', 'abnormal clonal deletion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916728, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916729, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916730, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916731, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916732, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001473', 'reduced long-term potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916733, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916734, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031117', 'subdural hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916735, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916736, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916737, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916738, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916739, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003477', 'abnormal nerve fiber response', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916740, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003489', 'increased channel response threshold', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916741, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002635', 'reduced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916742, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916743, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003466', 'decreased single cell response threshold', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916744, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916745, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916746, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916747, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000921', 'demyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916748, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916749, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916750, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003880', 'abnormal central pattern generator function', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916751, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002915', 'abnormal synaptic depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916752, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916753, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006060', 'increased cerebral infarct size', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916754, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003488', 'decreased channel response intensity', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916755, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916756, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916757, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003481', 'decreased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916758, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003009', 'abnormal cytokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916759, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916760, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002634', 'abnormal sensorimotor gating', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916761, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001845', 'abnormal inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916762, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916763, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916764, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003468', 'increased single cell response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916765, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916766, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916767, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916768, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916769, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916770, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916771, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916772, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916773, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916774, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916775, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916776, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916777, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916778, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916779, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003480', 'increased nerve fiber response intensity', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916780, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916781, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916782, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916783, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001876', 'decreased inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916784, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006052', 'cerebellum hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916785, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013438', 'dysmyelination', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916786, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002420', 'abnormal adaptive immunity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916787, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916788, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001790', 'abnormal immune system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916789, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916790, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916791, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002498', 'abnormal acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916792, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916793, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021009', 'abnormal synaptic physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916794, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916795, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916796, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006082', 'CNS inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916797, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916798, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916799, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021015', 'increased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916800, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916801, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014120', 'focal seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916802, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916803, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916804, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916805, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916806, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020424', 'increased kindling response', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916807, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916808, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002578', 'impaired ability to fire action potentials', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916809, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916810, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916811, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916812, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916813, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916814, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916815, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916816, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916817, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006080', 'brain ischemia', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916818, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916819, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003464', 'abnormal single cell response threshold', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916820, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916821, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001499', 'abnormal kindling response', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916822, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916823, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001496', 'audiogenic seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916824, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916825, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916826, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916827, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916828, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006051', 'brainstem hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916829, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916830, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916831, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916832, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916833, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916834, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916835, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916836, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014254', 'increased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916837, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916838, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004751', 'increased length of allograft survival', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916839, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916840, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916841, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916842, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916843, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916844, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916845, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001475', 'reduced long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916846, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916847, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916848, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916849, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916850, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916851, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916852, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916853, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916854, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916855, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916856, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916857, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916858, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916859, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001900', 'impaired synaptic plasticity', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916860, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916861, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916862, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916863, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916864, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916865, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004811', 'abnormal neuron physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916866, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916867, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005025', 'abnormal response to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916868, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916869, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916870, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0020154', 'impaired humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916871, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916872, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916873, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0005402', 'abnormal action potential', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916874, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021016', 'decreased tau protein phosphorylation', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916875, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916876, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916877, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916878, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000948', 'nonconvulsive seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916879, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004994', 'abnormal brain wave pattern', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916880, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916881, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001898', 'abnormal long-term depression', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916882, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916883, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916884, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916885, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916886, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916887, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916888, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916889, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916890, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003889', 'enhanced sensorimotor gating', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916891, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916892, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002922', 'decreased post-tetanic potentiation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916893, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0000920', 'abnormal myelination', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916894, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008921', 'increased neurotransmitter release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916895, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0002207', 'abnormal long-term potentiation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916896, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916897, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916898, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001916', 'intracerebral hemorrhage', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916899, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916900, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916901, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014255', 'increased paired-pulse inhibition', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916902, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916903, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0014253', 'decreased paired-pulse ratio', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(916904, 'HP:0032663', 'Focal motor status epilepticus', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916905, 'HP:0000915', 'Pectus excavatum of inferior sternum', 'MP:0004677', 'truncated ribs', 0.4166666666666667, 10.607147267911275, 2.1022951017787754, 'UPHENO:0087317', 'abnormal thoracic rib cage morphology'),
(916906, 'HP:0000915', 'Pectus excavatum of inferior sternum', 'MP:0010099', 'abnormal thoracic cage shape', 0.4444444444444444, 10.607147267911275, 2.1712410448006993, 'UPHENO:0087317', 'abnormal thoracic rib cage morphology'),
(916907, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916908, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004012', 'increased pulmonary artery pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916909, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916910, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011920', 'abnormal S wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916911, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0002626', 'increased heart rate', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916912, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0013135', 'poor circulation in tail', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916913, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003899', 'abnormal QT interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916914, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010636', 'bundle branch block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916915, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916916, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916917, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004485', 'increased response of heart to induced stress', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916918, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0008817', 'hematoma', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916919, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003897', 'abnormal ST segment', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916920, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010560', 'intraventricular block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916921, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916922, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003823', 'increased left ventricle developed pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916923, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916924, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011927', 'abnormal cardiac valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916925, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0020096', 'high mean heart rate adaptation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916926, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916927, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0031130', 'right-to-left shunt', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916928, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916929, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006047', 'aortic valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916930, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0031129', 'left-to-right shunt', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916931, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004216', 'salt-resistant hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916932, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004122', 'abnormal sinus arrhythmia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916933, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0031128', 'cardiovascular shunt', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916934, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916935, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916936, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916937, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003034', 'increased pulmonary vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916938, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001598', 'abnormal blood viscosity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916939, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006138', 'congestive heart failure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916940, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916941, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010512', 'absent PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916942, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916943, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004486', 'decreased response of heart to induced stress', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916944, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916945, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003929', 'decreased heart rate variability', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916946, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0012046', 'decreased susceptibility to hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916947, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006114', 'cardiac murmur', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916948, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916949, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(916950, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916951, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916952, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001633', 'poor circulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916953, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0000249', 'abnormal blood vessel physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916954, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011926', 'abnormal heart valve physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916955, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004010', 'increased diastolic filling velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916956, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003824', 'decreased left ventricle developed pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916957, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916958, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010514', 'fragmented QRS complex', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916959, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003394', 'increased cardiac output', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916960, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001914', 'hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916961, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004085', 'abnormal heartbeat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916962, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006265', 'increased pulse pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916963, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003901', 'abnormal PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916964, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0009732', 'ventricular premature beat', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916965, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006266', 'decreased pulse pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916966, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916967, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010393', 'shortened QRS complex duration', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916968, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916969, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006045', 'mitral valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916970, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010394', 'decreased QRS amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916971, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010515', 'abnormal Q wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916972, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010554', 'shortened HV interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916973, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011918', 'abnormal PQ interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916974, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010571', 'shortened ST segment', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916975, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010559', 'heart block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916976, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0000233', 'abnormal blood flow velocity', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916977, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010695', 'abnormal blood pressure regulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916978, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0008776', 'increased right ventricle peak pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916979, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916980, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0005532', 'abnormal vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916981, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004484', 'abnormal response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916982, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0031170', 'abnormal vasculature physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916983, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011929', 'abnormal aortic valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916984, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010516', 'absent Q wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916985, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001636', 'irregular heartbeat', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916986, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010756', 'decreased right ventricle peak pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916987, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003393', 'decreased cardiac output', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916988, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0009384', 'cardiac valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916989, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010552', 'abnormal HV interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916990, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0031302', 'syncope', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916991, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0031192', 'coronary artery spasm', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916992, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916993, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916994, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0012045', 'increased susceptibility to hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916995, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010637', 'sinus bradycardia', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916996, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004070', 'abnormal P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916997, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010513', 'abnormal ventricular activation time', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916998, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(916999, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917000, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917001, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917002, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917003, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917004, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003233', 'prolonged QT interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917005, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010634', 'increased QRS amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917006, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006048', 'pulmonary valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917007, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917008, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006049', 'semilunar valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917009, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917010, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917011, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003882', 'abnormal pulse pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917012, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010510', 'absent P wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917013, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003820', 'increased left ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917014, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003928', 'increased heart rate variability', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917015, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011953', 'prolonged PQ interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917016, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004877', 'abnormal systemic vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917017, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003547', 'abnormal pulmonary pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917018, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010509', 'decreased P wave amplitude', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917019, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0005435', 'hemoperitoneum', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917020, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010553', 'prolonged HV interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917021, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011952', 'decreased cardiac stroke volume', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917022, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0008950', 'ventricular tachycardia', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917023, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011919', 'abnormal R wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917024, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917025, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917026, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010511', 'shortened PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917027, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010504', 'abnormal RR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917028, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917029, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0005333', 'decreased heart rate', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917030, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917031, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917032, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010520', 'sinoatrial block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917033, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010570', 'prolonged ST segment', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917034, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917035, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0009698', 'heart hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917036, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917037, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0020097', 'low mean heart rate adaptation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917038, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004878', 'increased systemic vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917039, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001629', 'abnormal heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917040, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917041, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001634', 'internal hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917042, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011938', 'prolonged PP interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917043, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917044, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003900', 'shortened QT interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917045, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011936', 'abnormal PP interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917046, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004013', 'decreased pulmonary artery pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917047, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0002128', 'abnormal blood circulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917048, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917049, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917050, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917051, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001627', 'abnormal cardiac output', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917052, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917053, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0000343', 'abnormal response to cardiac infarction', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917054, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917055, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011928', 'abnormal mitral valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917056, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010505', 'abnormal T wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917057, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917058, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0013134', 'poor circulation in autopods', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917059, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010758', 'increased right ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917060, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0002842', 'increased systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917061, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0000231', 'hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917062, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0005330', 'cardiomyopathy', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917063, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917064, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917065, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0002952', 'ventricular cardiomyopathy', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917066, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917067, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917068, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917069, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011954', 'shortened PQ interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917070, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917071, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004072', 'abnormal frontal plane axis', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917072, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917073, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004217', 'salt-sensitive hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917074, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011951', 'increased cardiac stroke volume', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917075, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004011', 'decreased diastolic filling velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917076, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917077, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0001596', 'hypotension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917078, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0003898', 'abnormal QRS complex', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917079, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010519', 'atrioventricular block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917080, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0011937', 'shortened PP interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917081, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004156', 'abnormal QT variability', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917082, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0004879', 'decreased systemic vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917083, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0010631', 'increased Q wave amplitude', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917084, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006044', 'tricuspid valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917085, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917086, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917087, 'HP:0004763', 'Paroxysmal supraventricular tachycardia', 'MP:0009275', 'bruising', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(917088, 'HP:0020035', 'Lower limb dysmetria', 'MP:0003158', 'dysphagia', 0.4074074074074074, 10.749166272783702, 2.092675312365956, 'UPHENO:0074360', 'abnormally decreased rate of behavior process'),
(917089, 'HP:0012514', 'Lower limb pain', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917090, 'HP:0012514', 'Lower limb pain', 'MP:0013639', 'decreased bone stiffness', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917091, 'HP:0012514', 'Lower limb pain', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917092, 'HP:0012514', 'Lower limb pain', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917093, 'HP:0012514', 'Lower limb pain', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917094, 'HP:0012514', 'Lower limb pain', 'MP:0013636', 'abnormal bone stiffness', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917095, 'HP:0012514', 'Lower limb pain', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917096, 'HP:0012514', 'Lower limb pain', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917097, 'HP:0012514', 'Lower limb pain', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917098, 'HP:0012514', 'Lower limb pain', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917099, 'HP:0012514', 'Lower limb pain', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917100, 'HP:0012514', 'Lower limb pain', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917101, 'HP:0012514', 'Lower limb pain', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917102, 'HP:0012514', 'Lower limb pain', 'MP:0020080', 'increased bone mineralization', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917103, 'HP:0012514', 'Lower limb pain', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917104, 'HP:0012514', 'Lower limb pain', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917105, 'HP:0012514', 'Lower limb pain', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917106, 'HP:0012514', 'Lower limb pain', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917107, 'HP:0012514', 'Lower limb pain', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917108, 'HP:0012514', 'Lower limb pain', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917109, 'HP:0012514', 'Lower limb pain', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917110, 'HP:0012514', 'Lower limb pain', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917111, 'HP:0012514', 'Lower limb pain', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917112, 'HP:0012514', 'Lower limb pain', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917113, 'HP:0012514', 'Lower limb pain', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917114, 'HP:0012514', 'Lower limb pain', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917115, 'HP:0012514', 'Lower limb pain', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917116, 'HP:0012514', 'Lower limb pain', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917117, 'HP:0012514', 'Lower limb pain', 'MP:0013637', 'increased femur stiffness', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917118, 'HP:0012514', 'Lower limb pain', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917119, 'HP:0012514', 'Lower limb pain', 'MP:0013644', 'increased vertebra maximal load', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917120, 'HP:0012514', 'Lower limb pain', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917121, 'HP:0012514', 'Lower limb pain', 'MP:0013638', 'decreased femur stiffness', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917122, 'HP:0012514', 'Lower limb pain', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917123, 'HP:0012514', 'Lower limb pain', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917124, 'HP:0012514', 'Lower limb pain', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917125, 'HP:0012514', 'Lower limb pain', 'MP:0013625', 'increased femur yield load', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917126, 'HP:0012514', 'Lower limb pain', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917127, 'HP:0012514', 'Lower limb pain', 'MP:0001800', 'abnormal humoral immune response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917128, 'HP:0012514', 'Lower limb pain', 'MP:0013642', 'decreased vertebra stiffness', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917129, 'HP:0012514', 'Lower limb pain', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917130, 'HP:0012514', 'Lower limb pain', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917131, 'HP:0012514', 'Lower limb pain', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917132, 'HP:0012514', 'Lower limb pain', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917133, 'HP:0012514', 'Lower limb pain', 'MP:0013641', 'increased vertebra stiffness', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917134, 'HP:0012514', 'Lower limb pain', 'MP:0000064', 'failure of bone resorption', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917135, 'HP:0012514', 'Lower limb pain', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917136, 'HP:0012514', 'Lower limb pain', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917137, 'HP:0012514', 'Lower limb pain', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917138, 'HP:0012514', 'Lower limb pain', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917139, 'HP:0012514', 'Lower limb pain', 'MP:0013634', 'increased femur fracture load', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917140, 'HP:0012514', 'Lower limb pain', 'MP:0001542', 'abnormal bone strength', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917141, 'HP:0012514', 'Lower limb pain', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917142, 'HP:0012514', 'Lower limb pain', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917143, 'HP:0012514', 'Lower limb pain', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917144, 'HP:0012514', 'Lower limb pain', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917145, 'HP:0012514', 'Lower limb pain', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917146, 'HP:0012514', 'Lower limb pain', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917147, 'HP:0012514', 'Lower limb pain', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917148, 'HP:0012514', 'Lower limb pain', 'MP:0031169', 'abnormal joint physiology', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917149, 'HP:0012514', 'Lower limb pain', 'MP:0020039', 'increased bone ossification', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917150, 'HP:0012514', 'Lower limb pain', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917151, 'HP:0012514', 'Lower limb pain', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917152, 'HP:0012514', 'Lower limb pain', 'MP:0020137', 'decreased bone mineralization', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917153, 'HP:0012514', 'Lower limb pain', 'MP:0002419', 'abnormal innate immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917154, 'HP:0012514', 'Lower limb pain', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917155, 'HP:0012514', 'Lower limb pain', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917156, 'HP:0012514', 'Lower limb pain', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917157, 'HP:0012514', 'Lower limb pain', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917158, 'HP:0012514', 'Lower limb pain', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917159, 'HP:0012514', 'Lower limb pain', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917160, 'HP:0012514', 'Lower limb pain', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917161, 'HP:0012514', 'Lower limb pain', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917162, 'HP:0012514', 'Lower limb pain', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917163, 'HP:0012514', 'Lower limb pain', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917164, 'HP:0012514', 'Lower limb pain', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917165, 'HP:0012514', 'Lower limb pain', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917166, 'HP:0012514', 'Lower limb pain', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917167, 'HP:0012514', 'Lower limb pain', 'MP:0008069', 'abnormal joint mobility', 0.40625, 5.059610039003922, 1.4336898473328683, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917168, 'HP:0012514', 'Lower limb pain', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917169, 'HP:0012514', 'Lower limb pain', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917170, 'HP:0012514', 'Lower limb pain', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917171, 'HP:0012514', 'Lower limb pain', 'MP:0003116', 'rickets', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917172, 'HP:0012514', 'Lower limb pain', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917173, 'HP:0012514', 'Lower limb pain', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917174, 'HP:0012514', 'Lower limb pain', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917175, 'HP:0012514', 'Lower limb pain', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917176, 'HP:0012514', 'Lower limb pain', 'MP:0008271', 'abnormal bone ossification', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917177, 'HP:0012514', 'Lower limb pain', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917178, 'HP:0012514', 'Lower limb pain', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917179, 'HP:0012514', 'Lower limb pain', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917180, 'HP:0012514', 'Lower limb pain', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917181, 'HP:0012514', 'Lower limb pain', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917182, 'HP:0012514', 'Lower limb pain', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917183, 'HP:0012514', 'Lower limb pain', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917184, 'HP:0012514', 'Lower limb pain', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917185, 'HP:0012514', 'Lower limb pain', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917186, 'HP:0012514', 'Lower limb pain', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917187, 'HP:0012514', 'Lower limb pain', 'MP:0002999', 'abnormal bone healing', 0.41935483870967744, 5.059610039003922, 1.456630341521264, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917188, 'HP:0012514', 'Lower limb pain', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917189, 'HP:0012514', 'Lower limb pain', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917190, 'HP:0012514', 'Lower limb pain', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917191, 'HP:0012514', 'Lower limb pain', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917192, 'HP:0012514', 'Lower limb pain', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917193, 'HP:0012514', 'Lower limb pain', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917194, 'HP:0012514', 'Lower limb pain', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917195, 'HP:0012514', 'Lower limb pain', 'MP:0013627', 'increased vertebra yield load', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917196, 'HP:0012514', 'Lower limb pain', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917197, 'HP:0012514', 'Lower limb pain', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917198, 'HP:0012514', 'Lower limb pain', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917199, 'HP:0012514', 'Lower limb pain', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917200, 'HP:0012514', 'Lower limb pain', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917201, 'HP:0012514', 'Lower limb pain', 'MP:0004149', 'increased bone strength', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917202, 'HP:0012514', 'Lower limb pain', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917203, 'HP:0012514', 'Lower limb pain', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917204, 'HP:0012514', 'Lower limb pain', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917205, 'HP:0012514', 'Lower limb pain', 'MP:0013632', 'increased femur maximal load', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917206, 'HP:0012514', 'Lower limb pain', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917207, 'HP:0012514', 'Lower limb pain', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917208, 'HP:0012514', 'Lower limb pain', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917209, 'HP:0012514', 'Lower limb pain', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917210, 'HP:0012514', 'Lower limb pain', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917211, 'HP:0012514', 'Lower limb pain', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917212, 'HP:0012514', 'Lower limb pain', 'MP:0013640', 'increased bone stiffness', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917213, 'HP:0012514', 'Lower limb pain', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917214, 'HP:0012514', 'Lower limb pain', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917215, 'HP:0012514', 'Lower limb pain', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917216, 'HP:0012514', 'Lower limb pain', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917217, 'HP:0012514', 'Lower limb pain', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917218, 'HP:0012514', 'Lower limb pain', 'MP:0001533', 'abnormal skeleton physiology', 0.48148148148148145, 5.059610039003922, 1.5608038112774407, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917219, 'HP:0012514', 'Lower limb pain', 'MP:0020138', 'delayed bone mineralization', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917220, 'HP:0012514', 'Lower limb pain', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917221, 'HP:0012514', 'Lower limb pain', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917222, 'HP:0012514', 'Lower limb pain', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917223, 'HP:0012514', 'Lower limb pain', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917224, 'HP:0012514', 'Lower limb pain', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917225, 'HP:0012514', 'Lower limb pain', 'MP:0031306', 'abnormal cartilage physiology', 0.43333333333333335, 5.059610039003922, 1.4807085072924941, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917226, 'HP:0012514', 'Lower limb pain', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917227, 'HP:0012514', 'Lower limb pain', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917228, 'HP:0012514', 'Lower limb pain', 'MP:0020040', 'decreased bone ossification', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917229, 'HP:0012514', 'Lower limb pain', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917230, 'HP:0012514', 'Lower limb pain', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917231, 'HP:0012514', 'Lower limb pain', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917232, 'HP:0012514', 'Lower limb pain', 'MP:0002998', 'abnormal bone remodeling', 0.4642857142857143, 5.059610039003922, 1.532678916461666, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917233, 'HP:0012514', 'Lower limb pain', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917234, 'HP:0012514', 'Lower limb pain', 'MP:0002896', 'abnormal bone mineralization', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917235, 'HP:0012514', 'Lower limb pain', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917236, 'HP:0012514', 'Lower limb pain', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917237, 'HP:0012514', 'Lower limb pain', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917238, 'HP:0012514', 'Lower limb pain', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917239, 'HP:0012514', 'Lower limb pain', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917240, 'HP:0012514', 'Lower limb pain', 'MP:0004945', 'abnormal bone resorption', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917241, 'HP:0012514', 'Lower limb pain', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917242, 'HP:0012514', 'Lower limb pain', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4482758620689655, 5.059610039003922, 1.5060215974438333, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917243, 'HP:0012514', 'Lower limb pain', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917244, 'HP:0012514', 'Lower limb pain', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917245, 'HP:0009742', 'Stiff shoulders', 'MP:0030863', 'decreased joint mobility', 0.4594594594594595, 12.700256672302759, 2.415626847353005, 'UPHENO:0076672', 'decreased skeletal joint mobility'),
(917246, 'HP:0009742', 'Stiff shoulders', 'MP:0008069', 'abnormal joint mobility', 0.4166666666666667, 12.04236264912775, 2.24001140706989, 'UPHENO:0076944', 'abnormal skeletal joint mobility'),
(917247, 'HP:0009742', 'Stiff shoulders', 'MP:0030798', 'joint contracture', 0.40540540540540543, 12.04236264912775, 2.2095336412484303, 'UPHENO:0076944', 'abnormal skeletal joint mobility'),
(917248, 'HP:0009742', 'Stiff shoulders', 'MP:0030797', 'joint laxity', 0.40540540540540543, 12.04236264912775, 2.2095336412484303, 'UPHENO:0076944', 'abnormal skeletal joint mobility'),
(917249, 'HP:0031814', 'Palilalia', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917250, 'HP:0031814', 'Palilalia', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917251, 'HP:0031814', 'Palilalia', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917252, 'HP:0031814', 'Palilalia', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917253, 'HP:0031814', 'Palilalia', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917254, 'HP:0031814', 'Palilalia', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917255, 'HP:0031814', 'Palilalia', 'MP:0002578', 'impaired ability to fire action potentials', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917256, 'HP:0031814', 'Palilalia', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917257, 'HP:0031814', 'Palilalia', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917258, 'HP:0031814', 'Palilalia', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917259, 'HP:0031814', 'Palilalia', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917260, 'HP:0031814', 'Palilalia', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917261, 'HP:0031814', 'Palilalia', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917262, 'HP:0031814', 'Palilalia', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917263, 'HP:0031814', 'Palilalia', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917264, 'HP:0031814', 'Palilalia', 'MP:0003889', 'enhanced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917265, 'HP:0031814', 'Palilalia', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917266, 'HP:0031814', 'Palilalia', 'MP:0002635', 'reduced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917267, 'HP:0031814', 'Palilalia', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917268, 'HP:0031814', 'Palilalia', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917269, 'HP:0031814', 'Palilalia', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917270, 'HP:0031814', 'Palilalia', 'MP:0003467', 'abnormal single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917271, 'HP:0031814', 'Palilalia', 'MP:0008814', 'decreased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917272, 'HP:0031814', 'Palilalia', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917273, 'HP:0031814', 'Palilalia', 'MP:0003474', 'abnormal summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917274, 'HP:0031814', 'Palilalia', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917275, 'HP:0031814', 'Palilalia', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917276, 'HP:0031814', 'Palilalia', 'MP:0002634', 'abnormal sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917277, 'HP:0031814', 'Palilalia', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917278, 'HP:0031814', 'Palilalia', 'MP:0021015', 'increased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917279, 'HP:0031814', 'Palilalia', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917280, 'HP:0031814', 'Palilalia', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917281, 'HP:0031814', 'Palilalia', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917282, 'HP:0031814', 'Palilalia', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917283, 'HP:0031814', 'Palilalia', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917284, 'HP:0031814', 'Palilalia', 'MP:0005402', 'abnormal action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917285, 'HP:0031814', 'Palilalia', 'MP:0003477', 'abnormal nerve fiber response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917286, 'HP:0031814', 'Palilalia', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917287, 'HP:0031814', 'Palilalia', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917288, 'HP:0031814', 'Palilalia', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917289, 'HP:0031814', 'Palilalia', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917290, 'HP:0031814', 'Palilalia', 'MP:0006080', 'brain ischemia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917291, 'HP:0031814', 'Palilalia', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917292, 'HP:0031814', 'Palilalia', 'MP:0004994', 'abnormal brain wave pattern', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917293, 'HP:0031814', 'Palilalia', 'MP:0003464', 'abnormal single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(917294, 'HP:0011254', 'Type II cryptotia', 'MP:0002177', 'abnormal outer ear morphology', 0.4186046511627907, 10.255471829629862, 2.0719527522972223, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917295, 'HP:0011254', 'Type II cryptotia', 'MP:0000023', 'abnormal ear position', 0.40425531914893614, 10.255471829629862, 2.036130898913413, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917296, 'HP:0011254', 'Type II cryptotia', 'MP:0000018', 'small ears', 0.4375, 10.255471829629862, 2.118199453654699, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917297, 'HP:0011254', 'Type II cryptotia', 'MP:0000017', 'big ears', 0.4375, 10.255471829629862, 2.118199453654699, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917298, 'HP:0011254', 'Type II cryptotia', 'MP:0003735', 'cup-shaped ears', 0.5, 11.115294171581601, 2.3574662427680275, 'UPHENO:0005986', 'abnormal shape of external ear'),
(917299, 'HP:0011254', 'Type II cryptotia', 'MP:0030045', 'abnormal forehead shape', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(917300, 'HP:0011254', 'Type II cryptotia', 'MP:0030071', 'abnormal face shape', 0.425531914893617, 6.5236679405794336, 1.6661419239923307, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(917301, 'HP:0011254', 'Type II cryptotia', 'MP:0003736', 'folded helix', 0.45454545454545453, 11.115294171581601, 2.2477558678886815, 'UPHENO:0005986', 'abnormal shape of external ear'),
(917302, 'HP:0011254', 'Type II cryptotia', 'MP:0003716', 'anteriorly rotated ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917303, 'HP:0011254', 'Type II cryptotia', 'MP:0000020', 'scaly ears', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917304, 'HP:0011254', 'Type II cryptotia', 'MP:0006290', 'proboscis', 0.45454545454545453, 6.5236679405794336, 1.7220056937636088, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(917305, 'HP:0011254', 'Type II cryptotia', 'MP:0003713', 'abnormal ear rotation', 0.4117647058823529, 10.255471829629862, 2.0549553137750456, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917306, 'HP:0011254', 'Type II cryptotia', 'MP:0003715', 'posteriorly rotated ears', 0.40384615384615385, 10.255471829629862, 2.035100207428027, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917307, 'HP:0011254', 'Type II cryptotia', 'MP:0000053', 'excessive ear growth', 0.42, 10.255471829629862, 2.0754031339584467, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917308, 'HP:0011254', 'Type II cryptotia', 'MP:0030074', 'coarse facial features', 0.4166666666666667, 6.5236679405794336, 1.6486949309200385, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(917309, 'HP:0011254', 'Type II cryptotia', 'MP:0020290', 'floppy ears', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917310, 'HP:0011254', 'Type II cryptotia', 'MP:0000022', 'abnormal ear shape', 0.5681818181818182, 11.115294171581601, 2.5130674587115642, 'UPHENO:0005986', 'abnormal shape of external ear'),
(917311, 'HP:0011254', 'Type II cryptotia', 'MP:0011495', 'abnormal head shape', 0.46511627906976744, 6.5236679405794336, 1.7419139354196116, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(917312, 'HP:0011254', 'Type II cryptotia', 'MP:0003737', 'ossification of pinnae', 0.4090909090909091, 10.255471829629862, 2.048272514569165, 'UPHENO:0086699', 'abnormal external ear morphology'),
(917313, 'HP:0011254', 'Type II cryptotia', 'MP:0009578', 'otocephaly', 0.45454545454545453, 6.5236679405794336, 1.7220056937636088, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(917314, 'HP:0011254', 'Type II cryptotia', 'MP:0030368', 'trigonocephaly', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(917315, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0002138', 'abnormal hepatobiliary system morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917316, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0000468', 'abnormal esophageal epithelium morphology', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917317, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0003119', 'abnormal digestive system development', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917318, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0000474', 'abnormal foregut morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917319, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0003300', 'gastrointestinal ulcer', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917320, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0003160', 'abnormal esophagus development', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917321, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0003943', 'abnormal hepatobiliary system development', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917322, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0009705', 'abnormal midgut morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917323, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0008786', 'abnormal hindgut morphology', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917324, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0000467', 'abnormal esophagus morphology', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917325, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0003301', 'peptic ulcer', 0.4444444444444444, 5.838135946814261, 1.6108156590600318, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917326, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0010352', 'gastrointestinal tract polyps', 0.46153846153846156, 5.838135946814261, 1.6415006192947488, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917327, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0000462', 'abnormal digestive system morphology', 0.48, 5.838135946814261, 1.674008737871713, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917328, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0004547', 'esophageal ulcer', 0.42857142857142855, 5.838135946814261, 1.5817895760563088, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917329, 'HP:0034476', 'Positive fecal Clostridium botulinum test', 'MP:0000477', 'abnormal intestine morphology', 0.41379310344827586, 5.838135946814261, 1.5542780934521376, 'UPHENO:0076803', 'abnormal digestive system morphology'),
(917330, 'HP:0000913', 'Posterior rib fusion', 'MP:0000154', 'rib fusion', 0.5306122448979592, 15.87018167374507, 2.901880894324287, 'UPHENO:0078126', 'abnormally fused rib and rib'),
(917331, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020219', 'increased tear production', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917332, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(917333, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012034', 'abnormal a-wave shape', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917334, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020958', 'abnormal c-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917335, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012038', 'abnormal a-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917336, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0003101', 'high myopia', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917337, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012144', 'decreased b-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917338, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012150', 'increased b-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917339, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0002001', 'blindness', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917340, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012031', 'abnormal b-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917341, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020960', 'increased c-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917342, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0003100', 'myopia', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917343, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0006148', 'binocular blindness', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(917344, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012146', 'increased b-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917345, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0003859', 'abnormal Harderian gland physiology', 0.425, 9.175301480945878, 1.9747159617023402, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(917346, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0013145', 'eye discharge', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917347, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0006152', 'tunnel vision', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917348, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4722222222222222, 9.175301480945878, 2.081533390289742, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(917349, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020974', 'abnormal FO-wave shape', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917350, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0010749', 'absent visual evoked potential', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917351, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012145', 'increased a-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917352, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020962', 'increased c-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917353, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020978', 'abnormal FO-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917354, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012154', 'decreased b-wave latency', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917355, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020218', 'abnormal tear production', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917356, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917357, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0014157', 'alacrima', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917358, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0006149', 'decreased visual acuity', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917359, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020979', 'decreased FO-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917360, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0011832', 'abnormal visual acuity', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917361, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020976', 'increased FO-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917362, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0003096', 'increased corneal light-scattering', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917363, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012030', 'abnormal a-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917364, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0006153', 'hypermetropia', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917365, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020439', 'absent b-wave', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917366, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020975', 'abnormal FO-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917367, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012149', 'decreased b-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917368, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0001337', 'dry eyes', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917369, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0006251', 'eyelid apraxia', 0.4594594594594595, 13.944182255188847, 2.5311630610399747, 'UPHENO:0078742', 'abnormality of eyelid physiology'),
(917370, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012153', 'increased b-wave latency', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917371, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0005257', 'abnormal intraocular pressure', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917372, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0013476', 'abnormal Harderian gland porphyrin secretion', 0.4146341463414634, 9.175301480945878, 1.950485400349759, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(917373, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917374, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012152', 'decreased a-wave latency', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917375, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012040', 'abnormal c-wave shape', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917376, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0006145', 'legal blindness', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(917377, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0005253', 'abnormal eye physiology', 0.47058823529411764, 5.772412880326452, 1.6481594554963, 'UPHENO:0075997', 'abnormal orbital region'),
(917378, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0013468', 'chromodacryorrhea', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917379, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020980', 'increased FO-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917380, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0004022', 'abnormal cone electrophysiology', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917381, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0006147', 'monocular blindness', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(917382, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012039', 'abnormal b-wave implicit time', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917383, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0001389', 'abnormal eye movement', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(917384, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012035', 'abnormal b-wave shape', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917385, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020220', 'decreased tear production', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917386, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0005551', 'abnormal eye electrophysiology', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917387, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0004021', 'abnormal rod electrophysiology', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917388, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0014179', 'abnormal blood-retina barrier function', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(917389, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020963', 'decreased c-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917390, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0008145', 'hemeralopia', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917391, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012033', 'abnormal ERG implicit time', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917392, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0010748', 'abnormal visual evoked potential', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917393, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917394, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0008144', 'nyctalopia', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(917395, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0006150', 'double vision', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917396, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0003011', 'delayed dark adaptation', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917397, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020860', 'abnormal cornea physiology', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917398, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0005260', 'ocular hypotension', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917399, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917400, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020959', 'decreased c-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917401, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0031497', 'increased visual acuity', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917402, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012147', 'increased a-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917403, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012032', 'abnormal ERG latency', 0.4444444444444444, 5.772412880326452, 1.6017230833388914, 'UPHENO:0075997', 'abnormal orbital region'),
(917404, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012036', 'abnormal a-wave latency', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917405, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020977', 'decreased FO-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917406, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0014132', 'abnormal tear film physiology', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917407, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012151', 'increased a-wave latency', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917408, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0005258', 'ocular hypertension', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917409, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012148', 'decreased a-wave implicit time', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917410, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012143', 'decreased a-wave amplitude', 0.42105263157894735, 5.772412880326452, 1.5590027690230905, 'UPHENO:0075997', 'abnormal orbital region'),
(917411, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0006190', 'retina ischemia', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917412, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.41025641025641024, 5.772412880326452, 1.5388857614522904, 'UPHENO:0075997', 'abnormal orbital region'),
(917413, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0001999', 'photosensitivity', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917414, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0020961', 'abnormal c-wave amplitude', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917415, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0002090', 'abnormal vision', 0.45714285714285713, 5.772412880326452, 1.6244436945368907, 'UPHENO:0075997', 'abnormal orbital region'),
(917416, 'HP:0032032', 'Horizontal eyelid laxity', 'MP:0012037', 'abnormal b-wave latency', 0.43243243243243246, 5.772412880326452, 1.579929917067169, 'UPHENO:0075997', 'abnormal orbital region'),
(917417, 'HP:0009933', 'Narrow naris', 'MP:0013789', 'small external nares', 0.5, 15.87018167374507, 2.816929327631869, 'UPHENO:0069217', 'decreased size of the external naris'),
(917418, 'HP:0009933', 'Narrow naris', 'MP:0030190', 'small snout', 0.41509433962264153, 5.913369942082322, 1.5667183509019862, 'UPHENO:0087472', 'abnormal face morphology'),
(917419, 'HP:0009933', 'Narrow naris', 'MP:0003102', 'sclera thinning', 0.42857142857142855, 9.804092483287297, 2.0498180215348, 'UPHENO:0080790', 'decreased thickness of the anatomical entity'),
(917420, 'HP:0009933', 'Narrow naris', 'MP:0030043', 'small forehead', 0.4074074074074074, 5.913369942082322, 1.552143909933821, 'UPHENO:0087472', 'abnormal face morphology'),
(917421, 'HP:0009933', 'Narrow naris', 'MP:0013788', 'external nares atresia', 0.4067796610169492, 13.732678149995134, 2.3635088666450748, 'UPHENO:0087110', 'abnormal external naris morphology'),
(917422, 'HP:0009933', 'Narrow naris', 'MP:0030064', 'small face', 0.4230769230769231, 5.913369942082322, 1.581711212614917, 'UPHENO:0087472', 'abnormal face morphology'),
(917423, 'HP:0009933', 'Narrow naris', 'MP:0003775', 'thin lip', 0.4067796610169492, 9.804092483287297, 1.997024140297364, 'UPHENO:0080790', 'decreased thickness of the anatomical entity'),
(917424, 'HP:0003038', 'Fibular hypoplasia', 'MP:0002764', 'short tibia', 0.4367816091954023, 10.906707549770182, 2.182624400718608, 'UPHENO:0046538', 'decreased length of long bone'),
(917425, 'HP:0003038', 'Fibular hypoplasia', 'MP:0002765', 'short fibula', 0.47058823529411764, 13.062826751687464, 2.4793572935398793, 'UPHENO:0020827', 'abnormal fibula morphology'),
(917426, 'HP:0000549', 'Abnormal conjugate eye movement', 'MP:0014179', 'abnormal blood-retina barrier function', 0.40425531914893614, 8.795504987450572, 1.8856377371536375, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(917427, 'HP:0010309', 'Bifid sternum', 'MP:0000153', 'rib bifurcation', 0.5357142857142857, 12.437222266468964, 2.5812395554754755, 'UPHENO:0081680', 'bifurcated anatomical entity in independent continuant'),
(917428, 'HP:0010309', 'Bifid sternum', 'MP:0013175', 'bifurcated tail', 0.49056603773584906, 12.437222266468964, 2.470076688627654, 'UPHENO:0081680', 'bifurcated anatomical entity in independent continuant'),
(917429, 'HP:0010309', 'Bifid sternum', 'MP:0004320', 'split sternum', 0.5964912280701754, 16.607147267911277, 3.1473826695492013, 'UPHENO:0055800', 'bifurcated sternum'),
(917430, 'HP:5201006', 'Incomplete cleft soft palate', 'MP:0013546', 'cleft soft palate', 0.4025974025974026, 15.384754846574829, 2.4887471428067633, 'UPHENO:0033582', 'abnormal incomplete closing of the soft palate'),
(917431, 'HP:0410050', 'Decreased level of 1,5 anhydroglucitol in serum', 'MP:0005560', 'decreased circulating glucose level', 0.42857142857142855, 10.668547812575419, 2.138278461009706, 'UPHENO:0052116', 'abnormal independent continuant carbohydrate level'),
(917432, 'HP:0410050', 'Decreased level of 1,5 anhydroglucitol in serum', 'MP:0008822', 'decreased blood uric acid level', 0.40350877192982454, 9.791230332350247, 1.9876738482680443, 'UPHENO:0079822', 'decreased role blood level'),
(917433, 'HP:0410050', 'Decreased level of 1,5 anhydroglucitol in serum', 'MP:0013404', 'decreased circulating lactate level', 0.41818181818181815, 9.791230332350247, 2.023490672728489, 'UPHENO:0079822', 'decreased role blood level'),
(917434, 'HP:0410050', 'Decreased level of 1,5 anhydroglucitol in serum', 'MP:0013278', 'decreased fasting circulating glucose level', 0.41379310344827586, 10.668547812575419, 2.101088172507736, 'UPHENO:0052116', 'abnormal independent continuant carbohydrate level'),
(917435, 'HP:0410050', 'Decreased level of 1,5 anhydroglucitol in serum', 'MP:0005566', 'decreased blood urea nitrogen level', 0.4107142857142857, 9.791230332350247, 2.0053424077237483, 'UPHENO:0079822', 'decreased role blood level'),
(917436, 'HP:0410050', 'Decreased level of 1,5 anhydroglucitol in serum', 'MP:0000189', 'hypoglycemia', 0.42105263157894735, 10.668547812575419, 2.119438635962528, 'UPHENO:0052116', 'abnormal independent continuant carbohydrate level'),
(917437, 'HP:0031002', 'Neuritis', 'MP:0008313', 'abnormal parasympathetic postganglionic fiber morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917438, 'HP:0031002', 'Neuritis', 'MP:0000841', 'abnormal hindbrain morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917439, 'HP:0031002', 'Neuritis', 'MP:0020452', 'abnormal axon radial sorting', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917440, 'HP:0031002', 'Neuritis', 'MP:0008312', 'abnormal sympathetic postganglionic fiber morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917441, 'HP:0031002', 'Neuritis', 'MP:0000958', 'peripheral nervous system degeneration', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917442, 'HP:0031002', 'Neuritis', 'MP:0014063', 'Lafora bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917443, 'HP:0031002', 'Neuritis', 'MP:0001077', 'abnormal spinal nerve morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917444, 'HP:0031002', 'Neuritis', 'MP:0003861', 'abnormal nervous system development', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917445, 'HP:0031002', 'Neuritis', 'MP:0014064', 'argyrophilic inclusion bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917446, 'HP:0031002', 'Neuritis', 'MP:0003993', 'abnormal ventral spinal root morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917447, 'HP:0031002', 'Neuritis', 'MP:0001033', 'abnormal parasympathetic system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917448, 'HP:0031002', 'Neuritis', 'MP:0004997', 'increased CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917449, 'HP:0031002', 'Neuritis', 'MP:0000783', 'abnormal forebrain morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917450, 'HP:0031002', 'Neuritis', 'MP:0004996', 'abnormal CNS synapse formation', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917451, 'HP:0031002', 'Neuritis', 'MP:0008025', 'brain vacuoles', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917452, 'HP:0031002', 'Neuritis', 'MP:0003894', 'abnormal Purkinje cell innervation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917453, 'HP:0031002', 'Neuritis', 'MP:0002751', 'abnormal autonomic nervous system morphology', 0.5185185185185185, 7.61846258113911, 1.9875396677704371, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917454, 'HP:0031002', 'Neuritis', 'MP:0000961', 'abnormal dorsal root ganglion morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917455, 'HP:0031002', 'Neuritis', 'MP:0008310', 'abnormal sympathetic preganglionic fiber morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917456, 'HP:0031002', 'Neuritis', 'MP:0008319', 'abnormal sympathetic afferent fiber morphology', 0.45161290322580644, 7.61846258113911, 1.8548843641546513, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917457, 'HP:0031002', 'Neuritis', 'MP:0002152', 'abnormal brain morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917458, 'HP:0031002', 'Neuritis', 'MP:0031468', 'abnormal taste bud morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917459, 'HP:0031002', 'Neuritis', 'MP:0001044', 'abnormal enteric nervous system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917460, 'HP:0031002', 'Neuritis', 'MP:0012545', 'syringomyelia', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917461, 'HP:0031002', 'Neuritis', 'MP:0014065', 'Lewy bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917462, 'HP:0031002', 'Neuritis', 'MP:0001890', 'anencephaly', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917463, 'HP:0031002', 'Neuritis', 'MP:0004998', 'decreased CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917464, 'HP:0031002', 'Neuritis', 'MP:0002752', 'abnormal somatic nervous system morphology', 0.5185185185185185, 7.61846258113911, 1.9875396677704371, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917465, 'HP:0031002', 'Neuritis', 'MP:0012260', 'encephalomeningocele', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917466, 'HP:0031002', 'Neuritis', 'MP:0009688', 'abnormal spinal cord central canal morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917467, 'HP:0031002', 'Neuritis', 'MP:0014066', 'Rosenthal fibers', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917468, 'HP:0031002', 'Neuritis', 'MP:0001008', 'abnormal sympathetic ganglion morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917469, 'HP:0031002', 'Neuritis', 'MP:0000959', 'abnormal somatic sensory system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917470, 'HP:0031002', 'Neuritis', 'MP:0005623', 'abnormal meninges morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917471, 'HP:0031002', 'Neuritis', 'MP:0008318', 'abnormal splanchnic nerve morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917472, 'HP:0031002', 'Neuritis', 'MP:0013935', 'basal brain tissue herniation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917473, 'HP:0031002', 'Neuritis', 'MP:0001034', 'abnormal parasympathetic ganglion morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917474, 'HP:0031002', 'Neuritis', 'MP:0002778', 'meroanencephaly', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917475, 'HP:0031002', 'Neuritis', 'MP:0003632', 'abnormal nervous system morphology', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917476, 'HP:0031002', 'Neuritis', 'MP:0008317', 'abnormal paravertebral ganglion morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917477, 'HP:0031002', 'Neuritis', 'MP:0003994', 'abnormal dorsal spinal root morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917478, 'HP:0031002', 'Neuritis', 'MP:0002184', 'abnormal innervation', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917479, 'HP:0031002', 'Neuritis', 'MP:0001007', 'abnormal sympathetic system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917480, 'HP:0031002', 'Neuritis', 'MP:0008493', 'alpha-synuclein inclusion body', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917481, 'HP:0031002', 'Neuritis', 'MP:0000960', 'abnormal sensory ganglion morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917482, 'HP:0031002', 'Neuritis', 'MP:0008027', 'abnormal spinal cord white matter morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917483, 'HP:0031002', 'Neuritis', 'MP:0012711', 'diplomyelia', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917484, 'HP:0031002', 'Neuritis', 'MP:0001078', 'abnormal phrenic nerve morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917485, 'HP:0031002', 'Neuritis', 'MP:0020370', 'abnormal glymphatic system morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917486, 'HP:0031002', 'Neuritis', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917487, 'HP:0031002', 'Neuritis', 'MP:0002878', 'abnormal corticospinal tract morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917488, 'HP:0031002', 'Neuritis', 'MP:0000778', 'abnormal nervous system tract morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917489, 'HP:0031002', 'Neuritis', 'MP:0014149', 'abnormal lacrimal gland innervation pattern', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917490, 'HP:0031002', 'Neuritis', 'MP:0000972', 'abnormal mechanoreceptor morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917491, 'HP:0031002', 'Neuritis', 'MP:0020503', 'abnormal sympathetic trunk morphology', 0.45161290322580644, 7.61846258113911, 1.8548843641546513, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917492, 'HP:0031002', 'Neuritis', 'MP:0014067', 'Hirano bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917493, 'HP:0031002', 'Neuritis', 'MP:0003634', 'abnormal glial cell morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917494, 'HP:0031002', 'Neuritis', 'MP:0005277', 'abnormal brainstem morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917495, 'HP:0031002', 'Neuritis', 'MP:0021002', 'brain lesion', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917496, 'HP:0031002', 'Neuritis', 'MP:0001051', 'abnormal somatic motor system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917497, 'HP:0031002', 'Neuritis', 'MP:0008311', 'abnormal parasympathetic preganglionic fiber morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917498, 'HP:0031002', 'Neuritis', 'MP:0014062', 'nervous system inclusion bodies', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917499, 'HP:0031002', 'Neuritis', 'MP:0002924', 'delayed CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917500, 'HP:0031002', 'Neuritis', 'MP:0008026', 'abnormal brain white matter morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917501, 'HP:0031002', 'Neuritis', 'MP:0002653', 'abnormal ependyma morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917502, 'HP:0031002', 'Neuritis', 'MP:0009685', 'abnormal spinal cord motor column morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917503, 'HP:0031002', 'Neuritis', 'MP:0010800', 'abnormal submucous nerve plexus morphology', 0.45161290322580644, 7.61846258113911, 1.8548843641546513, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917504, 'HP:0031002', 'Neuritis', 'MP:0001052', 'abnormal innervation pattern to muscle', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917505, 'HP:0031002', 'Neuritis', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917506, 'HP:0031002', 'Neuritis', 'MP:0000913', 'abnormal brain development', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917507, 'HP:0031002', 'Neuritis', 'MP:0013915', 'abnormal brachial plexus formation', 0.5, 7.61846258113911, 1.951725208775445, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(917508, 'HP:0031002', 'Neuritis', 'MP:0003329', 'amyloid beta deposits', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917509, 'HP:0031002', 'Neuritis', 'MP:0008503', 'abnormal spinal cord grey matter morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917510, 'HP:0031002', 'Neuritis', 'MP:0000955', 'abnormal spinal cord morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(917511, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0002700', 'increased opacity of vitreous body', 0.40384615384615385, 7.832360208310102, 1.7785017699354968, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(917512, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0002864', 'abnormal ocular fundus morphology', 0.4166666666666667, 7.832360208310102, 1.806511394962459, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(917513, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0031290', 'bilateral microphthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917514, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0006248', 'lagophthalmos', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917515, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0014087', 'retrolental blood', 0.425531914893617, 7.832360208310102, 1.82562845003543, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(917516, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0003671', 'abnormal eyelid aperture', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(917517, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0001306', 'small lens', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(917518, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0002698', 'abnormal sclera morphology', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(917519, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0006164', 'ectropion', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(917520, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0001296', 'macrophthalmia', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917521, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0006200', 'vitreous body deposition', 0.42, 7.832360208310102, 1.8137230459720808, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(917522, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0005193', 'abnormal anterior eye segment morphology', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(917523, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0002699', 'abnormal vitreous body morphology', 0.42857142857142855, 7.832360208310102, 1.8321369500016838, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(917524, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0006225', 'ocular rupture', 0.4583333333333333, 8.581084971325078, 1.9831785795848023, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917525, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0001305', 'enlarged lens', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(917526, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0008841', 'ruptured lens capsule', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(917527, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0006186', 'retina fibrosis', 0.40350877192982454, 7.832360208310102, 1.7777587150587209, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(917528, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0009274', 'buphthalmos', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917529, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0006166', 'eyelid retraction', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(917530, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0005176', 'eyelids fail to open', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917531, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0003102', 'sclera thinning', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(917532, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0006209', 'calcified intraocular region', 0.4583333333333333, 8.581084971325078, 1.9831785795848023, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917533, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0001297', 'microphthalmia', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917534, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0001289', 'persistence of hyaloid vascular system', 0.4117647058823529, 7.832360208310102, 1.7958534176094256, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(917535, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0010081', 'posterior microphthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917536, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0006249', 'phthisis bulbi', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917537, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0002697', 'abnormal eye size', 0.4583333333333333, 8.581084971325078, 1.9831785795848023, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917538, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0031289', 'unilateral microphthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(917539, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0030063', 'abnormal face size', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(917540, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0003381', 'vitreal fibroplasia', 0.42, 7.832360208310102, 1.8137230459720808, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(917541, 'HP:0025158', 'Hyperautofluorescent retinal lesion', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.43478260869565216, 7.832360208310102, 1.8453655474222683, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(917542, 'HP:0034586', 'Glutathionuria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917543, 'HP:0034586', 'Glutathionuria', 'MP:0030632', 'increased urine creatine level', 0.41025641025641024, 11.094077685671904, 2.1334049044730112, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(917544, 'HP:0034586', 'Glutathionuria', 'MP:0030689', 'cystathioninuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917545, 'HP:0034586', 'Glutathionuria', 'MP:0020404', 'prolinuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917546, 'HP:0034586', 'Glutathionuria', 'MP:0030613', 'dicarboxylic aciduria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(917547, 'HP:0034586', 'Glutathionuria', 'MP:0011654', 'histidinuria', 0.5405405405405406, 11.226325483970346, 2.4633887320902836, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917548, 'HP:0034586', 'Glutathionuria', 'MP:0011517', 'hyperoxaluria', 0.4266666666666667, 10.47786425096631, 2.1143687979502594, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(917549, 'HP:0034586', 'Glutathionuria', 'MP:0030618', 'tryptophanuria', 0.5405405405405406, 11.226325483970346, 2.4633887320902836, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917550, 'HP:0034586', 'Glutathionuria', 'MP:0030616', 'hyperglycinuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917551, 'HP:0034586', 'Glutathionuria', 'MP:0002931', 'glutaricadicuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(917552, 'HP:0034586', 'Glutathionuria', 'MP:0020405', 'taurinuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917553, 'HP:0034586', 'Glutathionuria', 'MP:0030682', 'hydroxyprolinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917554, 'HP:0034586', 'Glutathionuria', 'MP:0020401', 'argininuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917555, 'HP:0034586', 'Glutathionuria', 'MP:0030614', 'methylmalonic aciduria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(917556, 'HP:0034586', 'Glutathionuria', 'MP:0020406', 'hyperthreoninuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917557, 'HP:0034586', 'Glutathionuria', 'MP:0030615', 'ethylmalonic aciduria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(917558, 'HP:0034586', 'Glutathionuria', 'MP:0011516', 'aspartylglucosaminuria', 0.5797101449275363, 11.226325483970346, 2.5510810989296564, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917559, 'HP:0034586', 'Glutathionuria', 'MP:0011765', 'oroticaciduria', 0.4927536231884058, 10.47786425096631, 2.272224806866592, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(917560, 'HP:0034586', 'Glutathionuria', 'MP:0020400', 'cystinuria', 0.5405405405405406, 11.226325483970346, 2.4633887320902836, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917561, 'HP:0034586', 'Glutathionuria', 'MP:0020402', 'ornithinuria', 0.5128205128205128, 11.226325483970346, 2.3993936716970112, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917562, 'HP:0034586', 'Glutathionuria', 'MP:0030617', 'hyperglutaminuria', 0.5194805194805194, 11.226325483970346, 2.4149238899539482, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917563, 'HP:0034586', 'Glutathionuria', 'MP:0011470', 'increased urine creatinine level', 0.4444444444444444, 11.094077685671904, 2.22051822636788, 'UPHENO:0051739', 'abnormal urine amino acid level'),
(917564, 'HP:0034586', 'Glutathionuria', 'MP:0013730', 'glutathionuria', 0.5, 11.226325483970346, 2.369211417747511, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917565, 'HP:0034586', 'Glutathionuria', 'MP:0030620', 'valinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917566, 'HP:0034586', 'Glutathionuria', 'MP:0020403', 'lysinuria', 0.5063291139240507, 11.226325483970346, 2.38415927213802, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917567, 'HP:0034586', 'Glutathionuria', 'MP:0003311', 'aminoaciduria', 0.5882352941176471, 11.226325483970346, 2.5697705876057757, 'UPHENO:0068169', 'increased level of amino acid in urine'),
(917568, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917569, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917570, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917571, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917572, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917573, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917574, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917575, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917576, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917577, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917578, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917579, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917580, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917581, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917582, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917583, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917584, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917585, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917586, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917587, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917588, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917589, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917590, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917591, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917592, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917593, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917594, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917595, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917596, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917597, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917598, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917599, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917600, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917601, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917602, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917603, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917604, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917605, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917606, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917607, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917608, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917609, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917610, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917611, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917612, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917613, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917614, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917615, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917616, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917617, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917618, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917619, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917620, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917621, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917622, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917623, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917624, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917625, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917626, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917627, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917628, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917629, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917630, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917631, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917632, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917633, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917634, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917635, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917636, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917637, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917638, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917639, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917640, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917641, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917642, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917643, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917644, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917645, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917646, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917647, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917648, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917649, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917650, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917651, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917652, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917653, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917654, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917655, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917656, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917657, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917658, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917659, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917660, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917661, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917662, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917663, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917664, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917665, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917666, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917667, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917668, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917669, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917670, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917671, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917672, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917673, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917674, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917675, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917676, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917677, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917678, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917679, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917680, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917681, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917682, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917683, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917684, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917685, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917686, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917687, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917688, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917689, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917690, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917691, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917692, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917693, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917694, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917695, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917696, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917697, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917698, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917699, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917700, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917701, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917702, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917703, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917704, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917705, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917706, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917707, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917708, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917709, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917710, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917711, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917712, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917713, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917714, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917715, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917716, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917717, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917718, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917719, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917720, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917721, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917722, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917723, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917724, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917725, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917726, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917727, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917728, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917729, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917730, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917731, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917732, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917733, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917734, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917735, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917736, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917737, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917738, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917739, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(917740, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917741, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917742, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(917743, 'HP:0032230', 'Cytoplasmic antineutrophil antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
